1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile (PCC) are precursors to PCP and are listed under which schedule?

Prepare for the Montana MPJE. Study with flashcards and multiple-choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile (PCC) are precursors to PCP and are listed under which schedule?

Explanation:
The important concept here is how the law regulates drugs and the chemicals used to make them. PCP is a controlled substance placed in a high-schedule category because of its high potential for abuse and limited accepted medical use. When a chemical serves as a direct precursor to a scheduled drug, the regulatory framework often extends a similar level of control to that precursor to prevent illicit production. 1-phenylcyclohexylamine and PCC are directly used to synthesize PCP, so they are kept under strict control to curb diversion and manufacturing. That’s why they’re treated as Schedule II materials, mirroring the level of control applied to PCP itself. Choosing a lower schedule would imply a lesser risk or medical value, which doesn’t align with the goal of preventing illicit synthesis of PCP. Schedule I would imply no accepted medical use, which also does not fit the regulatory approach for these precursors.

The important concept here is how the law regulates drugs and the chemicals used to make them. PCP is a controlled substance placed in a high-schedule category because of its high potential for abuse and limited accepted medical use. When a chemical serves as a direct precursor to a scheduled drug, the regulatory framework often extends a similar level of control to that precursor to prevent illicit production.

1-phenylcyclohexylamine and PCC are directly used to synthesize PCP, so they are kept under strict control to curb diversion and manufacturing. That’s why they’re treated as Schedule II materials, mirroring the level of control applied to PCP itself.

Choosing a lower schedule would imply a lesser risk or medical value, which doesn’t align with the goal of preventing illicit synthesis of PCP. Schedule I would imply no accepted medical use, which also does not fit the regulatory approach for these precursors.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy